SynthesisFrontiers in endocrinology2022

Efficacy and safety of bipolar androgen therapy in castration-resistant prostate cancer following abiraterone or enzalutamide resistance: A systematic review.

Xiangyun You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.